当前位置：
X-MOL 学术
›
J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma
Journal of Clinical Oncology ( IF 45.3 ) Pub Date : 2024-04-29 , DOI: 10.1200/jco.23.01684 Brian A. Van Tine 1 , Matthew A. Ingham 2 , Steven Attia 3 , Christian F. Meyer 4 , John D. Baird 5 , Esther Brooks-Asplund 5 , Dhiren D'Silva 5 , Ronald Kong 5 , Anthony Mwatha 5 , Kylie O'Keefe 5 , Marla Weetall 5 , Robert Spiegel 5 , Gary K. Schwartz 6
Journal of Clinical Oncology ( IF 45.3 ) Pub Date : 2024-04-29 , DOI: 10.1200/jco.23.01684 Brian A. Van Tine 1 , Matthew A. Ingham 2 , Steven Attia 3 , Christian F. Meyer 4 , John D. Baird 5 , Esther Brooks-Asplund 5 , Dhiren D'Silva 5 , Ronald Kong 5 , Anthony Mwatha 5 , Kylie O'Keefe 5 , Marla Weetall 5 , Robert Spiegel 5 , Gary K. Schwartz 6
Affiliation
Journal of Clinical Oncology, Ahead of Print.
中文翻译：
Unesbulin (PTC596) 联合达卡巴嗪治疗局部复发性、不可切除或转移性、复发性或难治性平滑肌肉瘤的 Ib 期研究
临床肿瘤学杂志，印刷前。
更新日期：2024-04-30
中文翻译：
Unesbulin (PTC596) 联合达卡巴嗪治疗局部复发性、不可切除或转移性、复发性或难治性平滑肌肉瘤的 Ib 期研究
临床肿瘤学杂志，印刷前。
京公网安备 11010802027423号